One Year Study of Rifaximin Delayed Release (DR) in Crohn's Disease

Stopped early · Phase 3 · Has a placebo group

Conditions studied: Crohn's Disease

In brief

The primary objective is to determine the efficacy of rifaximin DR also referred to as Extended Intestinal Release (EIR) tablets vs. placebo for the induction of clinical remission and endoscopic response following 16 weeks of treatment in participants presenting with active moderate Crohn's disease. A key secondary objective is to evaluate clinical and endoscopic remission following an additional 36 weeks of treatment.

Key facts

Study ID

NCT02240108

Run by

Bausch Health Americas, Inc.

People needed

81

Starts

2014-10-28

Expected to finish

2017-10-06

Last updated by the study team

2019-09-10

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Study site — Tucson, Arizona, United States
• Study site — Tucson, Arizona, United States
• Study site — Tucson, Arizona, United States
• Study site — Sherwood, Arkansas, United States
• Study site — Garden Grove, California, United States
• Study site — La Jolla, California, United States
• Study site — La Mirada, California, United States
• Study site — Laguna Hills, California, United States
• Study site — Los Angeles, California, United States
• Study site — Northridge, California, United States
• Study site — Oceanside, California, United States
• Study site — San Diego, California, United States
• Study site — Littleton, Colorado, United States
• Study site — Waterbury, Connecticut, United States
• Study site — Boca Raton, Florida, United States
• Study site — Clearwater, Florida, United States
• Study site — Coral Gables, Florida, United States
• Study site — Hollywood, Florida, United States
• Study site — Inverness, Florida, United States
• Study site — Lauderdale Lakes, Florida, United States
• Study site — Maitland, Florida, United States
• Study site — Miami, Florida, United States
• Study site — Miami, Florida, United States
• Study site — Miami, Florida, United States
• Study site — Huntsville, Alabama, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.